Intracranial Pressure Monitoring Market Size, Trends and Forecast 2026–2034

Market Overview:

According to IMARC Group’s latest research publication, “Intracranial Pressure Monitoring Market:  Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026-2034”, The global intracranial pressure monitoring market size reached USD 2.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.25% during 2026-2034.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How Intracranial Pressure Monitoring Is Reshaping Critical Neurological Care Worldwide

  • North America accounts for the largest regional share in the global market, driven by a high prevalence of traumatic brain injuries, with an estimated 2 million Americans sustaining some form of TBI each year, and the cost of treating, rehabilitating, and caring for TBI victims reaching approximately USD 30 Billion annually in the United States.
  • Monitors represent the dominant product type segment, driven by widespread demand for continuous, real-time ICP data in intensive care units and neurosurgical departments globally.
  • Invasive technology, particularly External Ventricular Drainage (EVD) and microtransducer systems, holds the largest technology segment share, owing to its high accuracy in critical care settings and ability to provide both monitoring and therapeutic cerebrospinal fluid drainage.
  • Intraventricular monitoring leads the monitoring type segment, as it remains the gold standard for simultaneous pressure measurement and CSF drainage in severe TBI and hydrocephalus management.
  • Traumatic Brain Injury dominates the application segment, accounting for the largest market share, with road traffic injuries responsible for 60% of TBI cases in India alone, followed by falls at 20%-25% and violence at 10%, according to the National Institute of Health (NIH).
  • In March 2026, Australian regulators approved M.scio, a coin-sized implantable sensor for hydrocephalus management, enabling real-time intracranial pressure monitoring that reduces hospital scans by over 60%, monitoring procedures by 90%, and radiation exposure by nearly half.

Download a sample PDF of this report: https://www.imarcgroup.com/intracranial-pressure-monitoring-market/requestsample

Key Trends in the Intracranial Pressure Monitoring Market

  • Increasing Prevalence of Neurological Disorders Driving Demand: The rising incidence of traumatic brain injuries, strokes, hydrocephalus, and other neurological conditions is directly elevating the need for continuous and precise ICP monitoring. According to the Centers for Disease Control and Prevention (CDC), an estimated 2.5 million people sustain a traumatic brain injury each year in the United States alone, with brain injuries being most common among men between the ages of 15 to 24, as well as children under 5 and adults over 75. This demographic and epidemiological burden is sustaining consistent demand for advanced ICP monitoring solutions across hospital and trauma center settings.
  • Technological Advancements Transforming Monitoring Accuracy: Rapid innovations including minimally invasive and non-invasive ICP monitoring techniques are improving accuracy, patient safety, and device usability while also reducing procedural risks. In June 2024, a Chinese research team published findings in Nature journal describing a mini-injectable ultrasonic sensor measuring just 8 cubic millimeters, made from biodegradable hydrogels and implanted through a puncture needle, which wirelessly monitors intracranial pressure by detecting shifts in ultrasound wave frequencies via an external probe. Such breakthroughs are creating new treatment and monitoring possibilities beyond the limitations of conventional clinical instruments.
  • Growing Awareness and Adoption of Early Diagnosis Tools: Increased awareness among healthcare providers and patients regarding the importance of early neurological intervention is fueling the adoption of ICP monitoring systems across hospitals and specialized trauma centers. In March 2024, researchers from King’s College London developed a deep learning framework for a non-invasive brain-age prediction tool aimed at early diagnosis of neurological diseases including Alzheimer’s, multiple sclerosis, strokes, and Parkinson’s disease, using models trained across multiple MRI types. Advancements like these, when combined with rising healthcare literacy, are creating a robust environment for market expansion.
  • Shift Toward Non-Invasive Monitoring Technologies: A growing clinical and commercial preference for non-invasive ICP monitoring is reshaping product development pipelines, as healthcare providers seek to minimize infection risks and complications associated with invasive procedures. Brain4Care received FDA clearance (FDA number K240821) for its non-invasive ICP monitor (nICPm), which generates waveforms equivalent to those from invasive monitors and has been validated to reflect intracranial pressure, positioning it as a clinically applicable alternative for neurocritical and emergency settings.
  • Hospitals Maintaining Dominant End-User Position: Hospitals continue to represent the largest end-user segment in the global ICP monitoring market, owing to their advanced medical infrastructure, specialized neurosurgical teams, and the critical care requirements of high-acuity TBI and stroke patients. The emphasis on early diagnosis, continuous monitoring in ICUs, and integration of the latest ICP monitoring technology drives consistent hospital spending on both invasive and non-invasive monitoring systems across North America, Europe, and Asia Pacific.
  • Government and Defense Investments Accelerating Innovation: Government-backed funding programs, particularly in the United States, are driving the development of next-generation non-invasive ICP monitoring platforms intended for both military and civilian applications. The Department of Defense has prioritized ICP monitoring as a critical gap in Prolonged Casualty Care (PFC), noting that tracking intracranial pressure in austere military and civilian environments has been a longstanding challenge, creating a clear pathway for new non-invasive diagnostic devices to enter high-priority procurement pipelines.

We explore the factors propelling the intracranial pressure monitoring market growth, including technological advancements, consumer behaviors, and regulatory changes.

Growth Factors in the Intracranial Pressure Monitoring Market

  • High Burden of Traumatic Brain Injuries Sustaining Demand: In the United States, approximately 100,000 people die from TBI each year and 500,000 more are permanently disabled, with around 80,000 people experiencing the onset of long-term disability following severe brain injury annually. An estimated 5.3 million Americans, representing more than 2% of the US population, are currently living with disabilities resulting from TBI, making ICP monitoring a medical necessity with deeply embedded demand across the country’s healthcare system.
  • Expanding Neurological Disorder Patient Pool in Emerging Economies: In India, an estimated 1.5 to 2 million persons are injured and approximately 1 million succumb to death every year due to traumatic brain injuries, with road traffic injuries accounting for the leading cause at 60%, according to the NIH. As healthcare infrastructure improves in South and Southeast Asia and awareness of neurological monitoring grows, demand for ICP devices is expanding well beyond established markets, creating substantial growth opportunities for manufacturers across the Asia Pacific region.
  • Integration of Telemedicine and Portable Devices Broadening Accessibility: Advancements in portable and wireless ICP monitoring devices, combined with telemedicine integration, are making monitoring accessible beyond traditional intensive care settings, including ambulatory and home care environments. The M.scio fully implanted sensor approved in Australia in March 2026 exemplifies this transition, as it allows clinicians to review intracranial pressure in real time and in everyday settings rather than only during a single hospital admission, a shift that is expanding the addressable market for ICP monitoring solutions.
  • Strategic Acquisitions and Consolidation Strengthening Market Capabilities: Leading medtech companies are pursuing acquisitions to expand their ICP monitoring portfolios and customer reach. ClearPoint Neuro acquired Irras Holdings, whose cornerstone IRRAflow system is both FDA-cleared and CE-marked and integrates continuous irrigation, aspiration, and real-time intracranial pressure monitoring. The acquisition brought more than 50 active customers and 10 additional patent families into ClearPoint Neuro’s installed base, with total combined revenue projected in the range of USD 54 million to USD 60 million for 2026.
  • Rising Healthcare Expenditure and Advanced Infrastructure in North America: North America leads the global market, backed by the highest levels of healthcare spending, a strong base of medical device manufacturers, and continuous R&D investment in ICP monitoring technologies. The region’s advanced healthcare infrastructure, combined with large-scale insurance coverage for neurosurgical and critical care procedures, ensures a steady uptake of both established invasive systems and newly cleared non-invasive alternatives across hospitals and trauma centers.

Leading Companies Operating in the Global Intracranial Pressure Monitoring Industry:

  • DePuy Synthes (Johnson & Johnson)
  • HeadSense Medical Ltd.
  • Integra Lifesciences Corporation
  • LINET Ltd.
  • Medtronic plc
  • Natus Medical Incorporated
  • Raumedic AG (Rehau)
  • Sophysa
  • Spiegelberg GmbH (SHS)

Intracranial Pressure Monitoring Market Report Segmentation:

Breakup By Product Type:

  • Monitors
  • Probes
  • Catheters and Kits
  • Other Accessories

Monitors account for the largest segment, driven by growing demand for continuous real-time ICP data in ICUs and neurosurgical units, along with advancements in both invasive and non-invasive monitor designs that enhance patient safety and clinical utility.

Breakup By Technology:

  • Invasive (External Ventricular Drainage, Microtransducer ICP Monitoring)
  • Non-invasive (Transcranial Doppler Ultrasonography, Tympanic Membrane Displacement, Optic Nerve Sheath Diameter, MRI/CT, Others)

Invasive technology holds the largest share, as EVD and microtransducer systems continue to offer the highest accuracy and therapeutic drainage capabilities required in critical care and severe TBI management.

Breakup By Monitoring Type:

  • Intraventricular
  • Intraparenchymal
  • Epidural
  • Others

Intraventricular monitoring leads the segment due to its superior accuracy and dual capability of simultaneously monitoring intracranial pressure and draining excess cerebrospinal fluid, making it the preferred approach for managing severe TBI and hydrocephalus in ICU settings.

Breakup By Application:

  • Traumatic Brain Injury
  • Intracerebral Hemorrhage
  • Meningitis
  • Others

Traumatic Brain Injury dominates the application segment, as the need for precise, real-time ICP data to guide treatment decisions, reduce secondary brain damage, and improve patient outcomes drives strong demand across emergency and critical care departments.

Breakup By End-User:

  • Hospitals
  • Home Care
  • Trauma Centers
  • Others

Hospitals hold the dominant end-user share, supported by their advanced infrastructure, availability of neurosurgical specialists, and emphasis on continuous ICP monitoring in intensive care settings to manage high-acuity neurological patients effectively.

Breakup By Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America leads the global market, driven by a high prevalence of TBIs, advanced healthcare infrastructure, significant healthcare expenditure, and strong adoption of innovative medical technologies, with approximately 5.3 million Americans currently living with TBI-related disabilities.

Recent News and Developments in the Intracranial Pressure Monitoring Market

  • March 2026: Australian regulators made their first approval of a medical device for intracranial pressure monitoring as part of hydrocephalus management, clearing M.scio, a coin-sized implantable sensor developed by B. Braun. The fully implanted device, positioned along the shunt tubing at the burr hole site with a 44 Hz sampling rate, reduced hospital scans by over 60%, monitoring procedures by 90%, and radiation exposure by nearly half, enabling real-time ICP review in everyday clinical and outpatient settings.
  • December 2025: CranioSense, a Massachusetts-based neurotechnology startup, was awarded approximately USD 5.5 million in total non-dilutive federal grant funding through the NIH Blueprint MedTech Program and the U.S. Department of Defense’s Joint Warfighter Medical Research Program (JWMRP), to support development and clinical validation of what it describes as the world’s first noninvasive intracranial pressure (ICP) diagnostic and monitoring system. The system uses near-infrared optical sensors and proprietary algorithms for real-time noninvasive brain pressure diagnosis, aimed at making ICP assessment as routine as blood pressure measurement in emergency departments.
  • 2025: ClearPoint Neuro announced the acquisition of Irras Holdings, whose cornerstone IRRAflow system is an FDA-cleared and CE-marked platform integrating continuous irrigation, aspiration, and real-time intracranial pressure monitoring. The deal brought more than 50 active customers and 10 additional patent families to ClearPoint Neuro’s portfolio, with total combined 2026 revenue projected in the range of USD 54 million to USD 60 million, signaling consolidation and strategic expansion in the ICP monitoring device market.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201-971-6302

 

Posted in Default Category on November 05 2026 at 06:13 AM

Comments (0)

AI Article